NS-293

Merck KGaA in licensing deal with Nerviano Medical for PARP inhibitor
Seeking Alpha
Wed, 09/21/22 - 08:01 pm
Merck KGaA
Nerviano Medical Sciences
NS-293
PARP inhibitors